跳至主要内容
临床试验/ACTRN12624000483550
ACTRN12624000483550尚未招募Unknown

Application of a clinical support tool in active surveillance for low risk thyroid cancer

Department of Endocrinology, Royal North Shore Hospital0 个研究点目标入组 80 人开始时间: 2024年4月19日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • •Participants will be eligible for inclusion in the study if all of the below are met:
  • •Age 18 or above
  • •Thyroid nodule 2cm or smaller
  • •Bethesda III, V or Bethesda VI result on FNA cytopathology
  • •Clinicians will be eligible for inclusion if they are involved in the treatment of patients with thyroid cancer.

排除标准

  • •Participants will be excluded from study if:
  • •Thyroid nodule >2cm in size
  • •Bethesda result other than BIII, BV or BVI
  • •If they are unable to provide informed consent

研究者

发起方
Department of Endocrinology, Royal North Shore Hospital

相似试验